{"retracted":true,"timestamp":1406851200000,"update":{"timestamp":null,"doi":null,"pmid":25929763,"type":"retraction"},"doi":"10.1007/s10549-014-3068-6","journal":"Breast cancer research and treatment","publisher":null,"title":"Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin."}
